Fig. 11
From: Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging
![Fig. 11](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12951-022-01566-8/MediaObjects/12951_2022_1566_Fig11_HTML.png)
The schematic diagram of the design and preparation of beta-cyclodextrin modified mesoporous bioactive glass nanoparticles/silk fibroin hybrid nanofibers. (the figure is reproduced from Wang et al. [291]with required copyright permission)